TSE:MFC

Manulife Financial (MFC.TO)

61.23
+0.17 (0.28%)
as of Aug 13, 2026, 8:00:00 pm Market Open.
1631 watching
0
Investor Insights
star iconAug 13, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC-T) has shown resilience and growth, particularly in Asia and wealth management, despite recent challenges such as a new tax on its products in Mainland China. The stock appears to be experiencing a phase of high expectations, as evidenced by its notable ranking among Canadian equities. While some experts express caution due to valuations approaching overbought territory, they also recognize MFC's solid fundamentals, including a healthy dividend yield and strong asset management. However, the stock has prompted mixed sentiments regarding its potential for further gains amidst a dynamic financial landscape, with some analysts suggesting it may be time to accumulate shares during a market pullback. Overall, the stock's performance is closely watched, with a general understanding that lower interest rates and strategic positioning may lead to a continued upward trajectory.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY
Likes this company.
BUY
Good international exposure, especially in China.
DON'T BUY
Expensive. Trading mildly above its “fair market value”. Brilliantly run and the acquisition has been managed well, but you are now paying top dollar.
BUY
One of his favourite stocks. Excellent franchise in Canada as well as they US with John Hancock and Asia in China and Japan. Solid earnings.
BUY
Prefers over Sun Life (SLF-T) as they have an edge on management and global diversification.
BUY
Believes it is now the #1 life insurance company in the US. Have tremendous fee revenue and growth opportunities in Asia. His favourite financial in the Canadian market. Defensive.
BUY
A very stable stock. A star Canadian financial institution. The best managed in the whole financial area in Canada. Has the best international exposure and the best earnings growth.
BUY
Good ROE. Good growth in the US through John Hancock and in Asia. Multiples are not bad.
TOP PICK
Great management. Likes their John Hancock acquisition in the US as well as their great franchises in Asia that are only going to get larger and larger. Trades at a higher ROE than the banks.
BUY
A great company. Trades at 15 X earnings. Low yield at 2%. 2nd largest life insurer in North America. The John Hancock acquisition was integrated very well. Have a great and growing franchise in Asia. Expect they will make another acquisition.
BUY
Since insurance companies tend to be cash cows, this company should have good long-term growth.
BUY
Good, solid company. Tremendous track record. Made some very important acquisitions in the US. Operates in the far east as well. Nice, long-term hold.
BUY
And interest rate sensitive company so has been under a little bit of pressure. Has outperformed the market by only falling 7/8% while the market was off 12%. About 1/3 of its earnings are Canadian, 1/3 from Asia. There are good prospects of growth from the Asian market.
HOLD
During this weak market, the share price was hanging on very well relative to the market. 2/3 days ago, people were looking for liquidity to cover their margins and this stock got hit. Very stable business and very fee based revenue.
BUY
The premier life insurance company in North America. Has the best management, the best growth prospects and a division in the far east which gives them great growth potential.
Showing 1,876 to 1,890 of 2,284 entries